Convalescent plasma as a potential therapy for COVID-19 - PubMed (original) (raw)

Comment

Convalescent plasma as a potential therapy for COVID-19

Long Chen et al. Lancet Infect Dis. 2020 Apr.

No abstract available

PubMed Disclaimer

Comment in

• Appropriate selection of convalescent plasma donors for COVID-19.
  Tedder RS, Semple MG. Tedder RS, et al. Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15. Lancet Infect Dis. 2021. PMID: 32553190 Free PMC article. No abstract available.

Comment on

• The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
  Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. Mair-Jenkins J, et al. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. J Infect Dis. 2015. PMID: 25030060 Free PMC article. Review.

Similar articles

• Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
  Tamburello A, Marando M. Tamburello A, et al. Swiss Med Wkly. 2020 Apr 28;150:w20264. doi: 10.4414/smw.2020.20264. eCollection 2020 Apr 20. Swiss Med Wkly. 2020. PMID: 32343358 No abstract available.
• Why should we use convalescent plasma for COVID-19?
  Franchini M. Franchini M. Eur J Intern Med. 2020 Jul;77:150-151. doi: 10.1016/j.ejim.2020.05.019. Epub 2020 May 16. Eur J Intern Med. 2020. PMID: 32425365 Free PMC article. No abstract available.
• Convalescent plasma for patients with COVID-19.
  Zeng F, Chen X, Deng G. Zeng F, et al. Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12528. doi: 10.1073/pnas.2006961117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398379 Free PMC article. No abstract available.
• Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
  Lindholm PF, Ramsey G, Kwaan HC. Lindholm PF, et al. Semin Thromb Hemost. 2020 Oct;46(7):796-803. doi: 10.1055/s-0040-1712157. Epub 2020 Jun 11. Semin Thromb Hemost. 2020. PMID: 32526774 Free PMC article. Review.
• Convalescent plasma in Covid-19: Possible mechanisms of action.
  Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, Rojas-Villarraga A, Ramírez-Santana C, Díaz-Coronado JC, Manrique R, Mantilla RD, Shoenfeld Y, Anaya JM. Rojas M, et al. Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5. Autoimmun Rev. 2020. PMID: 32380316 Free PMC article. Review.

Cited by

• A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.
  Chavda V, Yadav D, Parmar H, Brahmbhatt R, Patel B, Madhwani K, Jain M, Song M, Patel S. Chavda V, et al. Curr Top Med Chem. 2024;24(21):1883-1916. doi: 10.2174/0115680266296095240529114058. Curr Top Med Chem. 2024. PMID: 38859776 Review.
• From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
  Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R. Kumar A, et al. Vaccines (Basel). 2024 Apr 25;12(5):459. doi: 10.3390/vaccines12050459. Vaccines (Basel). 2024. PMID: 38793710 Free PMC article. Review.
• The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019.
  Shi M, Zhang C, Wang FS. Shi M, et al. Infect Dis Immun. 2021 Apr 20;1(1):52-58. doi: 10.1097/01.ID9.0000733568.58627.47. eCollection 2021 Apr. Infect Dis Immun. 2021. PMID: 38630075 Free PMC article. Review.
• Modelling the impact of plasma therapy and immunotherapy for recovery of COVID-19 infected individuals.
  Shah NH, Suthar AH, Jayswal EN, Shukla N, Shukla J. Shah NH, et al. Sao Paulo J Math Sci. 2021;15(1):344-364. doi: 10.1007/s40863-021-00232-5. Epub 2021 Apr 12. Sao Paulo J Math Sci. 2021. PMID: 38624564 Free PMC article.
• Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis, Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen-Antibody Interactions in Convalescent Plasma Therapy.
  Roy N, Kashyap J, Verma D, Tyagi RK, Prabhakar A. Roy N, et al. Trans Indian Natl Acad Eng. 2020;5(2):241-250. doi: 10.1007/s41403-020-00148-0. Epub 2020 Jul 8. Trans Indian Natl Acad Eng. 2020. PMID: 38624434 Free PMC article.

References

1. 1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001191. published online Jan 31. - DOI - PMC - PubMed
2. 1. Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583–591. - PMC - PubMed
3. 1. Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10:676–678. - PMC - PubMed
4. 1. Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. - PMC - PubMed
5. 1. WHO Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. http://apps.who.int/iris/rest/bitstreams/604045/retrieve

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations